/KRMD
KRMD Stock - KORU Medical Systems, Inc.
Healthcare|Medical - Instruments & SuppliesNASDAQ
$5.80+0.87%
+$0.05 (+0.87%) • Dec 19
74
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.BUY
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.100
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).57
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.97
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+3.4%upside
Target: $6.00
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for KRMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$5.74 – $5.86
TARGET (TP)$6.00
STOP LOSS$5.34
RISK/REWARD1:0.4
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.57
52W High$6.11
52W Low$1.86
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $33.65M | $28.52M | $27.90M | $23.49M | $24.18M |
| Gross Profit | $21.33M | $16.71M | $15.37M | $13.77M | $14.94M |
| Gross Margin | 63.4% | 58.6% | 55.1% | 58.6% | 61.8% |
| Operating Income | $-6,446,231 | $-10,269,979 | $-10,780,873 | $-7,029,535 | $-1,254,785 |
| Net Income | $-6,066,633 | $-13,741,062 | $-8,661,142 | $-4,562,823 | $-1,212,063 |
| Net Margin | -18.0% | -48.2% | -31.0% | -19.4% | -5.0% |
| EPS | $-0.13 | $-0.30 | $-0.19 | $-0.10 | $-0.03 |
Company Overview
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
4
80%
Hold / Neutral
1
20%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
4 Bullish1 Neutral/Bearish
Price Targets
$4
Average Target
↓ 29.6% Downside
Now
$4
Low
$4
Average
$5
High
Based on 6 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| February 14th 2025 | Piper Sandler | Downgrade | Neutral | $4.5 |
| July 25th 2024 | B. Riley Securities | Resumed | Buy | $4 |
| September 7th 2023 | Lake Street | Initiation | Buy | $4 |
| September 7th 2023 | B. Riley Securities | Initiation | Buy | $4.5 |
| November 10th 2022 | Canaccord Genuity | Upgrade | Buy | $4← $3 |
| November 10th 2022 | Piper Sandler | Upgrade | Overweight | $3.5← $3 |
Earnings History & Surprises
KRMDBeat Rate
26%
Last 19 quarters
Avg Surprise
-24.8%
EPS vs Estimate
Beats / Misses
5/11
3 met exactly
Latest EPS
$-0.02
Q4 2025
EPS Surprise History
Q1 24
-25.0%
$-0.02vs$-0.02
Q2 24
-47.4%
$-0.02vs$-0.01
Q3 24
-52.3%
$-0.02vs$-0.01
Q4 24
-21.1%
$-0.03vs$-0.02
Q1 25
0.0%
$-0.03vs$-0.03
Q2 25
-50.0%
$-0.03vs$-0.02
Q3 25
+133.3%
$0.01vs$-0.03
Q4 25
+33.3%
$-0.02vs$-0.03
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 11, 2026 | $-0.02 | — | — | — |
Q4 2025 | Nov 12, 2025 | $-0.03 | $-0.02 | +33.3% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | $-0.03 | $0.01 | +133.3% | ✓ BEAT |
Q2 2025 | May 7, 2025 | $-0.02 | $-0.03 | -50.0% | ✗ MISS |
Q1 2025 | Mar 12, 2025 | $-0.03 | $-0.03 | 0.0% | = MET |
Q4 2024 | Nov 13, 2024 | $-0.02 | $-0.03 | -21.1% | ✗ MISS |
Q3 2024 | Aug 7, 2024 | $-0.01 | $-0.02 | -52.3% | ✗ MISS |
Q2 2024 | May 1, 2024 | $-0.01 | $-0.02 | -47.4% | ✗ MISS |
Q1 2024 | Mar 13, 2024 | $-0.02 | $-0.02 | -25.0% | ✗ MISS |
Q4 2023 | Nov 8, 2023 | $-0.02 | $-0.03 | -40.0% | ✗ MISS |
Q3 2023 | Aug 9, 2023 | $-0.05 | $-0.05 | 0.0% | = MET |
Q2 2023 | May 4, 2023 | $-0.04 | $-0.05 | -25.0% | ✗ MISS |
Q1 2023 | Mar 8, 2023 | $-0.05 | $-0.04 | +20.0% | ✓ BEAT |
Q4 2022 | Nov 9, 2022 | $-0.05 | $-0.03 | +40.0% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $-0.06 | $-0.06 | 0.0% | = MET |
Q2 2022 | May 4, 2022 | $-0.06 | $-0.05 | +16.7% | ✓ BEAT |
Q1 2022 | Mar 2, 2022 | $-0.01 | $-0.02 | -40.0% | ✗ MISS |
Q4 2021 | Nov 10, 2021 | $-0.02 | $-0.02 | -14.3% | ✗ MISS |
Q3 2021 | Aug 11, 2021 | $-0.01 | $-0.02 | -50.0% | ✗ MISS |
Q2 2021 | May 12, 2021 | $-0.01 | $-0.03 | -350.1% | ✗ MISS |
Latest News
KORU Medical Systems Says On November 19, 2025 Co Entered Amended And Restated Manufacturing And Supply Agreement With Command Medical Products, Effective January 1, 2024; Agreement Expires December 31, 2026
➖ NeutralBenzinga•Nov 25, 2025, 10:03 PM
KORU Medical Systems To Present Latest Findings On Use Of FreedomEDGE Syringe Infusion System At ESID/EHA/SIOPE Focused Symposium 2025
➖ NeutralBenzinga•Nov 17, 2025, 09:08 PM
KORU Medical Systems shares are trading higher after the company reported better-than-expected Q3 sales results and raised its FY25 sales guidance above estimates.
📈 PositiveBenzinga•Nov 13, 2025, 02:17 PM
KORU Medical Systems Raises FY2025 Sales Guidance from $39.500M-$40.500M to $40.500M-$41.000M vs $39.940M Est
📈 PositiveBenzinga•Nov 12, 2025, 09:07 PM
KORU Medical Systems Q3 Sales $10.402M Beat $9.666M Estimate
📈 PositiveBenzinga•Nov 12, 2025, 09:06 PM
KORU Medical Systems Signs Agreement With A Pharmaceutical Firm For Collaboration On Infusion Systems In Subcutaneous Immunoglobulin Therapy For Both Commercial Drugs, Clinical Programs
📈 PositiveBenzinga•Nov 4, 2025, 09:18 PM
Forcast Orthopedics, And KORU Medical Systems Enters Partnership To Incorporate KORU's FreedomEDGE Infusion System Into ForCast's Platform For Treating Periprosthetic Joint Infection
📈 PositiveBenzinga•Sep 18, 2025, 12:03 PM
Cirtec Medical Appoints Shar Matin As CEO, Effective September 2, 2025
➖ NeutralBenzinga•Aug 28, 2025, 05:01 PM
Frequently Asked Questions about KRMD
What is KRMD's current stock price?
KORU Medical Systems, Inc. (KRMD) is currently trading at $5.80 per share. The stock has moved +0.87% today.
What is the analyst price target for KRMD?
The average analyst price target for KRMD is $6.00, based on 1 analyst.
What sector is KORU Medical Systems, Inc. in?
KORU Medical Systems, Inc. operates in the Healthcare sector, specifically within the Medical - Instruments & Supplies industry. The company is traded on the NASDAQ exchange.
What is KRMD's market cap?
KORU Medical Systems, Inc. has a market capitalization of $0.27 billion, making it a small-cap company.
Does KRMD pay dividends?
No, KORU Medical Systems, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorHIND
Vyome Holdings, Inc.
$3.68
Mkt Cap: $0.0B
INFU
InfuSystem Holdings, Inc.
$9.20
Mkt Cap: $0.2B
MXCT
MaxCyte, Inc.
$1.50
Mkt Cap: $0.2B
NYXH
Nyxoah S.A.
$4.85
Mkt Cap: $0.2B
OSUR
OraSure Technologies, Inc.
$2.39
Mkt Cap: $0.2B
PRE
Prenetics Global Limited
$17.48
Mkt Cap: $0.2B
PROF
Profound Medical Corp.
$7.63
Mkt Cap: $0.2B
STIM
Neuronetics, Inc.
$1.40
Mkt Cap: $0.1B
TLSI
TriSalus Life Sciences, Inc.
$7.42
Mkt Cap: $0.2B
UTMD
Utah Medical Products, Inc.
$56.60
Mkt Cap: $0.2B
Explore stocks similar to KRMD for comparison